Search

Discussing the finer points of AI as a catalyst for pharmaceutical innovation

We need to step away from assumptions on device interchangeability and find out what patients really want.

The repurposing of legacy small molecules drugs could be more advantageous than previously known. Case in point: Arsenic

Cryogenic freezing performed too fast can damage biopharma products. What’s the best way forward? An expert gives their view.

Developing modified release formulations can be complex – but a translational pharmaceutics approach can smooth the path

If we can edit RNA at the kilobase scale, we can treat more diseases at the genetic level

How pharmaceutical companies are aligning their sustainability goals with the complexities of the modern supply chain

Experts discuss the most exciting Alzheimer’s Disease treatment trends – and make bold predictions for the future

Here’s how paper is weighing down the future of advanced therapies.

Progress in Alzheimer’s Disease research, but a cure will take time. Delaying it and disseminating that research may buy scientists the time they need